Tevogen Bio Holdings (TVGN) Interest Coverage Ratio (2023 - 2025)
Tevogen Bio Holdings (TVGN) reported Interest Coverage Ratio of 421.49 for Q1 2025, down 122.46% on a YoY basis from 1876.95 in Q1 2024, and up 28.89% quarter-over-quarter from 592.68 in Q4 2024.
Tevogen Bio Holdings (TVGN) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Tevogen Bio Holdings has reported Interest Coverage Ratio for 3 years, with the latest figure at 421.49 in Q1 2025.
- For the quarter ending Q1 2025, Interest Coverage Ratio fell 122.46% year-over-year to 421.49; the trailing twelve-month figure through Dec 2025 stood at 1063.88 (down 265.54% YoY), and the FY2024 full-year result was 291.05, down 3870.5% from the prior year.
- Interest Coverage Ratio for Q1 2025 stood at 421.49, up from 592.68 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 6.33 in Q4 2023, with the low at 592.68 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 244.89 across 3 years, with a median of 189.47 in 2024.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 9266.18% — and 2025, when it plunged 122.46%.
- Tevogen Bio Holdings' Interest Coverage Ratio stood at 6.33 in 2023, then slumped by 9266.18% to 592.68 in 2024, then increased by 28.89% to 421.49 in 2025.
- The last three Interest Coverage Ratio figures came in at 421.49 (Q1 2025), 592.68 (Q4 2024), and 488.44 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -421.49 |
| Dec 31, 2024 | -592.68 |
| Sep 30, 2024 | -488.44 |
| Mar 31, 2024 | -189.47 |
| Dec 31, 2023 | -6.33 |
| Sep 30, 2023 | -7.75 |
| Mar 31, 2023 | -8.04 |